Notice of Annual General Meeting / Proxy Form
Released
Released
Announcement PDF
THETA GOLD MINES LIMITED
ACN 131 758 177
NOTICE OF 2023 ANNUAL GENERAL MEETING
TIME:
11.00 am (AEDT)
DATE:
Tuesday, 28 November 2023
PLACE:
The Boardroom (Servcorp)
Level 35, International Tower One
100 Barangaroo Avenue
SYDNEY NSW 2000
THIS IS AN IMPORTANT DOCUMENT AND SHOULD BE READ IN ITS ENTIRETY.
PLEASE READ IT CAREFULLY.
If you are unable to attend the Annual General Meeting, please complete the Proxy Form enclosed and return
it in accordance with the instructions set out on that form. If you are in any doubt as to how to vote, you should
consult your financial or legal adviser as soon as possible. Should you wish to discuss the matters in this Notice
of Meeting, please do not hesitate to contact the Company Secretary on (+61 2) 8046 7584.
NOTICE OF 2023 ANNUAL GENERAL MEETING
Notice is hereby given that the 2023 Annual General Meeting of Theta Gold Mines Limited (the Company) will
be held at:
Venue:
The Boardroom (Servcorp)
Level 35, International Tower One
100 Barangaroo Avenue
SYDNEY NSW 2000
Date:
11.00 am (AEDT), Tuesday, 28 November 2023
This Notice of Meeting should be read in conjunction with the accompanying Explanatory Statement.
AGENDA
BUSINESS
A.
TO RECEIVE THE FINANCIAL REPORT, DIRECTORS’ REPORT AND AUDITOR’S REPORT
“To receive and consider the financial report for the year ended 30 June 2023, together with the
declaration of the Directors, Directors’ report, Remuneration Report and the auditor’s report.”
Note: This item of business is for discussion and not for resolution.
B. RESOLUTIONS
RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
To consider and, if thought fit, to pass, with or without amendment the following resolution as a nonbinding resolution:
“That, for the purposes of section 250R(2) of the Corporations Act and for all other purposes, the
Remuneration Report (which forms part of the Directors’ report) for the year ended 30 June 2023 be
adopted.”
Note - the vote on this item is advisory only and does not bind the Directors or the Company.
Voting Prohibition Statement
A vote on this Resolution must not be cast (in any capacity) by or on behalf of any of the following persons:
(a) A member of the Key Management Personnel, details of whose remuneration are included in the
Remuneration Report; or
(b) A Closely Related Party of such a member.
However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote
is not cast on behalf of a person described above and either:
(a) The voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this
Resolution; or
(b) The voter is the Chair and the appointment of the Chair as proxy:
(i) Does not specify the way the proxy is to vote on this Resolution; and
(ii) Expressly authorises the Chair to exercise the proxy even though this Resolution is connected
directly or indirectly with the remuneration of a member of the Key Management Personnel.
2
RESOLUTION 2 – RE-ELECTION OF DIRECTOR: MR CHARLES WILLIAM GUY
To consider, and if thought fit, to pass, with or without amendment, the following resolution as an
ordinary resolution:
“That Mr Charles William Guy, an Executive Director of the Company, retiring by rotation pursuant to
clause 10.2 (b) of the Constitution and ASX Listing Rule 14.4 and 14.5 and, being eligible, offers himself
for re-election, be re-elected as a Director.”
RESOLUTION 3 – RATIFICATION OF PRIOR GRANT OF 1,000,000 OPTIONS TO 2INVEST AG
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the grant of
1,000,000 unlisted options with an exercise price of $0.14 per unlisted option and expiring on 6 March
2024 to 2Invest AG on 8 September 2023 on the terms and conditions set out in the Explanatory
Statement.”
A voting exclusion statement applies to this Resolution. Please see below.
RESOLUTION 4 – RATIFICATION OF PRIOR GRANT OF 1,000,000 OPTIONS TO 2INVEST AG
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary
resolution:
“That for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders ratify the grant of
1,000,000 unlisted options with an exercise price of $0.125 per unlisted option and expiring on 31 March
2024 to 2Invest AG on 3 October 2023 on the terms and conditions set out in the Explanatory Statement.”
A voting exclusion statement applies to this Resolution. Please see below.
RESOLUTION 5 – CHANGE OF AUDITOR
To consider and, if thought fit, pass with or without amendment the following resolution as an ordinary
resolution:
“That, for the purposes of section 327B of the Corporations Act 2001 (Cth) and for all other purposes, Hall
Chadwick NSW having consented in writing to act as auditor, be appointed as the auditor of the Company
and its controlled entities effective from the conclusion of the 2023 Annual General Meeting”.
RESOLUTION 6 - APPROVAL OF ADDITIONAL PLACEMENT CAPACITY
To consider and, if thought fit, pass the following resolution as a special resolution:
“That, for the purposes of Listing Rule 7.1A and for all other purposes, approval is given for the Company
to issue up to that number of Equity Securities equal to 10% of the issued capital of the Company at the
time of issue, calculated in accordance with the formula prescribed in Listing Rule 7.1A.2 and otherwise
on the terms and conditions set out in the Explanatory Statement.”
3
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the Resolution set
out below by or on behalf of the following persons:
RESOLUTION 3 –
RATIFICATION OF PRIOR
ISSUE OF 1,000,000
OPTIONS TO 2INVEST AG
RESOLUTION 4 –
RATIFICATION OF PRIOR
ISSUE OF 1,000,000
OPTIONS TO 2INVEST AG
A person who participated in the issue or is a counterparty to the agreement
being approved (namely 2Invest AG) or an associate of that person.
A person who participated in the issue or is a counterparty to the agreement
being approved (namely 2Invest AG) or an associate of that person.
However, this does not apply to a vote cast in favour of the Resolution by:
(a)
(b)
(c)
a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
the directions given to the proxy or attorney to vote on the Resolution in that way; or
the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with a
direction given to the Chair to vote on the Resolution as the Chair decides; or
a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i)
the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(ii)
the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
4
Voting at the meeting
Under regulation 7.11.37 of the Corporations Regulations 2001 (Cth), the Board has determined that a person
is eligible to vote at the meeting are those who are registered Shareholders at 5.00pm (AEDT) on Monday, 27
November 2023.
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance
with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
•
each Shareholder has a right to appoint a proxy;
•
the proxy need not be a Shareholder of the Company; and
•
a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the
proportion or number of votes each proxy is appointed to exercise. If the Shareholder appoints two proxies
and the appointment does not specify the proportion or number of the member’s votes, then in accordance
with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
•
if proxy holders vote, they must cast all directed proxies as directed; and
•
any directed proxies which are not voted will automatically default to the Chair, who must vote the proxies
as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 2 8046 7584.
By Order of the Board
Brent Hofman
Company Secretary
25 October 2023
5
EXPLANATORY STATEMENT
The purpose of this Explanatory Statement is to provide Shareholders with all information known to the
Company which is material to a decision on how to vote on each Resolution.
This Explanatory Statement should be read in conjunction with the Notice of Meeting.
1.
TO RECEIVE THE FINANCIAL REPORT, DIRECTORS’ REPORT AND AUDITOR’S REPORT
In accordance with the Corporations Act, the business of the Meeting will include receipt and consideration of
the annual financial report of the Company for the financial year ended 30 June 2023 together with the
declaration of the Directors, the Directors’ report and the auditor’s report.
The Company will not provide a hard copy of the Company’s annual financial report to Shareholders unless
specifically requested to do so. The Company’s annual financial report is available on its website at
www.thetagoldmines.com.
2.
RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
The Corporations Act requires that at a listed company’s annual general meeting, a resolution that the
remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory only
and does not bind the company or the directors of the company.
The remuneration report sets out the company’s remuneration arrangements for the directors and senior
management of the company. The remuneration report is part of the directors’ report contained in the annual
financial report of the company for a financial year.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about or
make comments on the remuneration report at the annual general meeting.
A company is required to put to its shareholders a resolution proposing the calling of another meeting of
shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive
annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted against
adoption of the remuneration report and at the first of those annual general meetings a Spill Resolution was
not put to vote. If required, the Spill Resolution must be put to vote at the second of those annual general
meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a shareholder
meeting (Spill Meeting) within 90 days of the second annual general meeting.
All of the directors of the company who were in office when the directors' report (as included in the company’s
annual financial report for the most recent financial year) was approved, other than the managing director of
the company, will cease to hold office immediately before the end of the Spill Meeting but may stand for reelection at the Spill Meeting.
Following the Spill Meeting those persons whose election or re-election as directors of the company is
approved will be the directors of the company.
At the Company’s previous Annual General Meeting the votes cast against the Remuneration Report for the
year ended 30 June 2022 were less than 25%. Accordingly, the Spill Resolution is not relevant for this Annual
General Meeting.
6
3.
RESOLUTION 2 – RE-ELECTION OF MR CHARLES WILLIAM GUY
Resolution 2 seeks approval for the re-election of Mr Charles William (Bill) Guy who is retiring as a Director by
rotation pursuant to clause 10.2 (b) of the Constitution, which states that at least one third of the Directors must
retire from office at each Annual General Meeting. Mr Guy is eligible for re-election under clause 10.2 and
offers himself for re-election as a Director.
Mr Guy, the Executive Chairman of Theta, was appointed as a director of the company in March 2018 and is
a professional mining executive and geologist with over 30 years’ experience in exploration and resource
development in Asia, Australia and Europe. In previous executive and geology roles he was involved in all
aspects of the mining industry inclusive of project acquisitions, project development (Cockatoo Island Fe),
project discovery (Mt Ida Fe), and large scale JV (Newcrest JV Au), in both the corporate and technical roles.
He is a Member of both the Audit and Risk and Nomination and Remuneration Committees and Chairman of
the operational Company, South African Subsidiary, Transvaal Gold Mining Estate Limited.
The Board considers that Mr Guy’s skills and experience will continue to enhance the Board’s ability to perform
its role. Accordingly, the Board (other than Mr Guy) supports the re-election of Mr Guy and recommends that
Shareholders vote in favour of Resolution 2.
Directors’ Recommendation
The Board considers that Mr Guys skills and experience will continue to enhance the Board’s ability to perform
its role. Accordingly, the Board (other than Mr Guy) support the re-election of Mr Guy and recommends that
Shareholders vote in favour of Resolution 2.
4.
RESOLUTIONS 3 AND 4 – RATIFICATION OF PRIOR ISSUE OF OPTIONS TO 2INVEST AG
FOR INTEREST DEFERRAL.
4.1
Background
On 30 July 2021, the Company announced that it had obtained a $6 million bond comprising 15
'bearer partial bonds' with a face value of $400,000 from 2Invest AG ("Bond"). 1 The Bond was
secured by:
(a)
a charge over all present and future dividends, distributions, sale proceeds, liquidation
proceeds and other payments received by the Company's South African subsidiary,
Transvaal Gold Mining Estates Limited in South Africa ("Transvaal"); and
(a)
a grant of an option right to acquire all present and future shares in Transvaal.
Repayment of the principal amount of the Bond was due by 31 January 2023.
On 3 April 2023, the Company announced that as part of ongoing funding arrangements, 2Invest AG
had agreed to defer interest payable on the Bond for the 31 January 2023 half-year period owing
from 31 January 2023 until such time as the Company has paid the outstanding interest ("Interest
Deferral").
In consideration of the Interest Deferral, the Company agreed to:
1
Refer to TGM ASX Release dated 2 August 2021 titled “Funding Package to Accelerate TGME Project”.
7
(a)
issue 1,000,000 Shares and grant 3,000,000 Options with an exercise price of $0.055 per
Option and expiring on 2 October 2023;
(b)
for each previous month that the outstanding interest under the Bond had not been paid,
grant 1,000,000 Options with an exercise price of $0.055 per Option and expiring on 2
October 2023 (being 3,000,000 Options for February, March and April 2023); and
(c)
for each following month that the outstanding interest under the Bond is not paid, grant
1,000,000 Options with an exercise price equal to, the at-market closing price that the
Company's Shares traded on ASX on the trading day before the Options were issued with
an expiry date that is 180 days after grant of the Options.
Details of these Shares and Options that were issued up to 31 August 2023 are set out in the Notice
of Extraordinary Meeting (EGM) subject to Shareholder approval on 13 October 2023 and are not
subject to approval in this notice for the 2023 AGM.
As further consideration and subsequent to the EGM on 13 October 2023, the following additional
Options that have been issued from 31 August 2023, up to 31 October 2023 for the Interest Deferral,
the Company agrees to:
(d)
for each following month that the outstanding interest under the Bond is not paid
subsequent from 31 August 2023 to 31 October 2023, grant 1,000,000 Options with an
exercise price equal to, the at-market closing price that the Company's Shares traded on
ASX on the trading day before the Options were issued with an expiry date that is 180 days
after grant of the Options.
Details of these Options that have been issued subsequent to 31 August 2023 and up to 31 October
2023 are set out in the table below ("Deferred Interest Options" respectively).
4.2
Resolution
Issue Date
Number of
Shares /
Options
Issue /
Exercise
Price
Securities
3
8
September
2023
1,000,000
$0.014
Unlisted Options expiring on 6
March 2024. Key terms are set out
in Annexure A.
4
3 October
2023
1,000,000
$0.125
Unlisted Options expiring on 31
March 2024. Key terms are set out
in Annexure B.
Listing Rule 7.1 and 7.1A
Broadly speaking, and subject to a number of exceptions set out in Listing Rule 7.2, Listing Rule 7.1
limits the amount of equity securities that a listed company can issue without the approval of its
shareholders over any 12 month period to 15% of the fully paid ordinary securities it had on issue at
the start of that 12 month period.
Under Listing Rule 7.1A, an eligible entity can seek approval from its members, by way of a special
resolution passed at its annual general meeting, to increase this 15% limit by an extra 10% to 25%.
The Company obtained approval to increase its limit to 25% at the annual general meeting held on
30 November 2022.
The issue of the Deferred Interest Shares and the grant of the Deferred Interest Options does not fit
within any of the exceptions set out in Listing Rule 7.2 and, as they have not yet been approved by
Shareholders, they effectively use up part of the combined 25% limit in Listing Rule 7.1 and Listing
Rule 7.1A, reducing the Company’s capacity to issue further equity securities without Shareholder
approval under Listing Rule 7.1 for the 12 month period following the relevant date of issue of the
Deferred Interest Shares and the grant of the Deferred Interest Options.
8
4.3
Listing Rule 7.4
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity securities
after it has been made or agreed to be made. If they do, the issue is taken to have been approved
under Listing Rule 7.1 and so does not reduce the company’s capacity to issue further equity
securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity securities in
the future without having to obtain Shareholder approval for such issues under Listing Rule 7.1.
Accordingly, Resolutions 3 and 4 seek Shareholder ratification pursuant to Listing Rule 7.4 for the
issue of the grant of the Deferred Interest Options.
4.4
Technical information required by Listing Rule 14.1A
If Resolutions 3 and 4 are passed, the Deferred Interest Options will be excluded in calculating the
Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively increasing the number of
equity securities the Company can issue without Shareholder approval over the 12 month period
following the relevant date of issue of the Deferred Interest Shares and the grant of the Deferred
Interest Options.
If Resolutions 3 and 4 are not passed, the Deferred Interest Options will be included in calculating
the Company’s combined 25% limit in Listing Rules 7.1 and 7.1A, effectively decreasing the number
of equity securities that the Company can issue without Shareholder approval over the 12 month
period following the relevant date of issue of the grant of the Deferred Interest Options.
4.5
Technical information required by ASX Listing Rule 7.5
The following information is provided pursuant to and in accordance with ASX Listing Rule 7.5 in
relation to Resolutions 3 and 4:
Names of the persons to whom
securities were issued
2Invest AG2
The number and class of the
securities
See table in paragraph 4.1 above.
Summary of material terms of
issue
A summary the terms of the Deferred Interest Options is set
out in the Annexures A & B.
Date of issue of the securities
See table in paragraph 4.1 above.
The price/consideration for the
securities
See table in paragraph 4.1 above.
The purpose of the issue of the
securities (including use of any
funds raised)
2
As mentioned above, Deferred Interest Options were issued
to obtain the Interest Deferral.
No funds were raised from the grant of the Deferred Interest
Options.
Summary of the terms of the
agreement
Terms of the agreement for the grant of the Deferred
Interest Options are set out in paragraph 4.1 above.
Voting exclusion
Please see the voting exclusion note in relation to
Resolutions 3 and 4 are on page 4.
2Invest AG is a substantial shareholder of the Company with a 6.074% interest as at 4 October 2023.
9
4.6
Technical information required by Guidance Note 21
Pursuant to and in accordance with paragraph 5.10 of Guidance Note 21, the following information
is provided in relation to Resolutions 3 and 4 for the Deferred Interest Options:
Party who can convert the
convertible security
4.7
2Invest AG3
When the convertible security
can be converted
Before the relevant expiry date – see table in paragraph 4.1
above.
Conditions that have to be met
before the convertible security
can be converted
Exercise price to be paid – see table in paragraph 4.1
above.
The class of equity securities
into which the convertible
securities convert
Fully paid ordinary shares
Price at which the convertible
securities convert
See exercise prices listed in the table in paragraph 4.1
above.
The number of equity securities
into which the convertible
securities convert
1 unlisted option coverts into 1 Share
Directors’ Recommendation
The Directors unanimously recommend that Shareholders vote in favour of Resolutions 3 and 4.
5.
RESOLUTIONS 5 – CHANGE OF AUDITOR.
5.1
Background
Under the Corporations Act, shareholder approval is required for the appointment of a new auditor.
The Company undertook an extensive review of its external audit requirements and subsequently
completed a tendering process to consider proposals from several Audit firm providers to find the
right fit for Theta Gold Mines Limited as it looks to progress its TGME Gold Mine Project in South
Africa. As a result, the Board has selected Hall Chadwick NSW to be appointed as the new auditor
of the Company.
In order to maintain good corporate governance, the Board also considers the rotation of its external
auditor’s good practice, Ernst & Young has been external auditor for the Company since November
2018.
Ernst & Young has been asked to resign as auditor with effect from the close of the Annual General
Meeting and is required to seek consent from ASIC for their resignation in accordance with section
329(5) of the Corporations Act.
Mr Brett Tang, a director and a member of the Company, has also nominated that Hall Chadwick
NSW be appointed as auditor under section 328B(1), assuming that ASIC consents to the resignation
3
2Invest AG is a substantial shareholder of the Company with a 6.074% interest as at 4 October 2023.
10
of Ernst & Young as auditor. In accordance with section 328B(3) of the Corporations Act, a copy of
the notice of nomination is included at the end of these Explanatory Notes at Annexure C.
Hall Chadwick NSW has also given its written consent under section 328A(1) to act as the Company’s
auditor, subject to shareholder approval found and attached at Annexure D of this notice.
If Resolution 5 is passed, the appointment of Hall Chadwick NSW as the Company’s external auditors
will take effect from the close of the AGM.
5.2
Directors’ Recommendation
The board recommends that shareholders vote in favour of Resolution 5 at the Company’s Annual
General Meeting. The Chairman intends to vote all undirected proxies in favour of Resolution 5.
6.
RESOLUTION 6 – APPROVAL OF ADDITIONAL PLACEMENT CAPACITY
6.1
General
Broadly speaking, and subject to a number of exceptions, ASX Listing Rule 7.1 limits the amount of
equity securities that a listed company can issue without the approval of its shareholders over any
12 month period to 15% of the fully paid ordinary securities it had on issue at the start of that period.
ASX Listing Rule 7.1A enables certain ‘eligible entities’ to issue equity securities of up to 10% of their
issued share capital through placements over a 12 month period commencing after the Annual
General Meeting (“Additional Placement Capacity”). ASX Listing Rules require that Shareholders
approve the Additional Placement Capacity by special resolution at an Annual General Meeting
before any equity securities are issued under the Additional Placement Capacity.
For the purposes of ASX Listing Rule 7.1A an ‘eligible entity’ is an entity that is not included in the
S&P/ASX 300 Index and has a market capitalisation of $300 million or less. The Company is an
‘eligible entity’. The Additional Placement Capacity is in addition to the Company’s 15% placement
capacity under ASX Listing Rule 7.1 and, as such, if the Additional Placement Capacity is approved,
the Directors will be allowed to issue equity securities of up to 25% of the Company’s issued share
capital without prior approval from shareholders.
The Company seeks Shareholder approval by way of a special resolution to have the ability to issue
equity securities under the Additional Placement Capacity should the need arise.
If Resolution 6 is passed, the Company will be able to issue equity securities up to the combined
25% limit in the ASX Listing Rules 7.1 and 7.1A without any further Shareholder approval.
If Resolution 6 is not passed, the Company will not be able to access the additional 10% capacity to
issue equity securities without Shareholder approval under ASX Listing Rule 7.1A, and will remain
subject to the 15% limit on issuing equity securities without Shareholder approval set out in ASX
Listing Rule 7.1.
Importantly:
(a)
Pursuant to ASX Listing Rule 7.1A.3 the issue price for each security issued under the
Additional Placement Capacity will not be less than 75% of the volume weighted average price
for securities in that class over the 15 trading days on which trades in that class were recorded
immediately before:
(i)
The date on which the price at which the securities are to be issued is agreed; or
11
(ii) If the securities are not issued within 10 trading days of the date above, the date on which
the securities are issued.
(b)
(c)
The issue of equity securities under the Additional Placement Capacity may result in voting
dilution of existing ordinary shareholders (as shown in the table below). There is also the risk
that:
(i)
The market price for equity securities in that class may be significantly lower on the issue
date than on the date of the Annual General Meeting; and
(ii)
The equity securities may be issued at a price that is at a discount to the market price for
those equity securities on the issue date.
Equity securities under the Additional Placement Capacity may be issued until the earlier of:
(i)
The date that is 12 months after the date of the Annual General Meeting at which the
approval is obtained;
(ii)
The time and date of the Company’s next Annual General Meeting; or
(iii)
The date of approval by ordinary shareholders of a significant change to the Company’s
activities under ASX Listing Rule 11.1.2 or the date of approval by ordinary shareholders
of a disposal of a major asset under ASX Listing Rule 11.2.
To be clear, any approval of the Additional Placement Capacity at this Annual General Meeting will
cease to be valid in the event that ordinary shareholders approve a transaction under ASX Listing Rule
11.1.2 or 11.2.
(d)
The Company may issue equity securities under the Additional Placement Capacity for the
purpose of raising funds for the exploration and development of the Company’s existing assets, the
acquisition of new assets or investments (including assets associated with such acquisition), to repay
debt or to fund working capital.
The Company will comply with the disclosure obligations under Listing Rules 7.1A(4) and 3.10.5A upon
issue of any equity securities.
(e)
The Company’s allocation policy for issues under the Additional Placement Capacity is dependent
on prevailing market conditions at the time of any proposed issue. The identity of the allottees of
the equity securities will be determined on a case-by-case basis having regard to the factors
including but not limited to the following:
(i)
The purpose of the issue;
(ii)
The methods of raising funds that are available to the Company, including rights issues or
other issues in which existing Shareholders may participate;
(iii)
The effect of the issue of the equity securities on the control of the Company;
(iv)
The financial situation and solvency of the Company;
(v)
Prevailing market conditions; and
(vi)
Advice from the Company’s advisors.
The allottees under the Additional Placement Capacity have not yet been determined but if such an
exercise was undertaken, allottees may include existing substantial Shareholders or new Shareholders
who are not related parties or associates of a related party of the Company.
12
Further, if the Company is successful in acquiring new resources, assets or investments, it is likely that
the allottees under the Additional Placement Capacity will be vendors of the new resources, assets or
investments.
(a)
A voting exclusion statement has not been included in this Notice as the Company is not
proposing to make an issue of equity securities under ASX Listing Rule 7.1A.
(b)
When the Company issues equity securities pursuant to the Additional Placement Capacity, it will
give to ASX:
(i)
(ii)
6.2
A list of the allottees of the equity securities and the number of equity securities allotted to
each (not for release to the market), i
Share your feedback
Discover